4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-037163
Options or other derivatives
- Chief Executive Officer acquired 65,886 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Robinson Chandler · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-02 | Grant or award : show line 1 in the form Stock Options | +16,753 | 16,753 | D |
| 2025-12-02 | Grant or award : show line 2 in the form Restricted Stock Units | +49,133 | 121,732 | D |
Loading xslF345X05/rdgdoc.xml…